Logo image of CHE

CHEMED CORP (CHE) Stock Fundamental Analysis

NYSE:CHE - New York Stock Exchange, Inc. - US16359R1032 - Common Stock - Currency: USD

415.18  -1.39 (-0.33%)

Fundamental Rating

7

CHE gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. CHE has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. CHE is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

In the past year CHE was profitable.
In the past year CHE had a positive cash flow from operations.
CHE had positive earnings in each of the past 5 years.
In the past 5 years CHE always reported a positive cash flow from operatings.
CHE Yearly Net Income VS EBIT VS OCF VS FCFCHE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

CHE's Return On Assets of 17.88% is amongst the best of the industry. CHE outperforms 98.06% of its industry peers.
The Return On Equity of CHE (26.13%) is better than 93.20% of its industry peers.
CHE's Return On Invested Capital of 22.08% is amongst the best of the industry. CHE outperforms 94.17% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CHE is significantly above the industry average of 9.72%.
The last Return On Invested Capital (22.08%) for CHE is above the 3 year average (21.96%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 17.88%
ROE 26.13%
ROIC 22.08%
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
CHE Yearly ROA, ROE, ROICCHE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

CHE has a Profit Margin of 12.40%. This is amongst the best in the industry. CHE outperforms 98.06% of its industry peers.
CHE's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 16.62%, CHE belongs to the top of the industry, outperforming 92.23% of the companies in the same industry.
CHE's Operating Margin has improved in the last couple of years.
The Gross Margin of CHE (34.82%) is better than 64.08% of its industry peers.
CHE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.62%
PM (TTM) 12.4%
GM 34.82%
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
CHE Yearly Profit, Operating, Gross MarginsCHE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CHE is creating value.
Compared to 1 year ago, CHE has less shares outstanding
The number of shares outstanding for CHE has been reduced compared to 5 years ago.
There is no outstanding debt for CHE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CHE Yearly Shares OutstandingCHE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CHE Yearly Total Debt VS Total AssetsCHE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

CHE has an Altman-Z score of 11.35. This indicates that CHE is financially healthy and has little risk of bankruptcy at the moment.
CHE's Altman-Z score of 11.35 is amongst the best of the industry. CHE outperforms 94.17% of its industry peers.
The Debt to FCF ratio of CHE is 0.00, which is an excellent value as it means it would take CHE, only 0.00 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.00, CHE belongs to the top of the industry, outperforming 92.23% of the companies in the same industry.
CHE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
CHE has a better Debt to Equity ratio (0.00) than 86.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.35
ROIC/WACC2.41
WACC9.15%
CHE Yearly LT Debt VS Equity VS FCFCHE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

CHE has a Current Ratio of 1.73. This is a normal value and indicates that CHE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.73, CHE is in the better half of the industry, outperforming 61.16% of the companies in the same industry.
A Quick Ratio of 1.70 indicates that CHE should not have too much problems paying its short term obligations.
The Quick ratio of CHE (1.70) is better than 64.08% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.7
CHE Yearly Current Assets VS Current LiabilitesCHE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

CHE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.97%.
CHE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.64% yearly.
CHE shows a small growth in Revenue. In the last year, the Revenue has grown by 7.37%.
CHE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.63% yearly.
EPS 1Y (TTM)-0.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%-21.94%
Revenue 1Y (TTM)7.37%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%3.85%

3.2 Future

Based on estimates for the next years, CHE will show a small growth in Earnings Per Share. The EPS will grow by 6.20% on average per year.
Based on estimates for the next years, CHE will show a small growth in Revenue. The Revenue will grow by 5.44% on average per year.
EPS Next Y1.83%
EPS Next 2Y8.03%
EPS Next 3Y6.2%
EPS Next 5YN/A
Revenue Next Year5.26%
Revenue Next 2Y5.73%
Revenue Next 3Y5.44%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CHE Yearly Revenue VS EstimatesCHE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
CHE Yearly EPS VS EstimatesCHE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15 20 25

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.56, which indicates a rather expensive current valuation of CHE.
70.87% of the companies in the same industry are more expensive than CHE, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.61, CHE is valued a bit cheaper.
A Price/Forward Earnings ratio of 15.37 indicates a correct valuation of CHE.
71.84% of the companies in the same industry are more expensive than CHE, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 37.13. CHE is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 18.56
Fwd PE 15.37
CHE Price Earnings VS Forward Price EarningsCHE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CHE.
CHE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CHE is cheaper than 62.14% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.28
EV/EBITDA 12.42
CHE Per share dataCHE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CHE has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)10.15
PEG (5Y)1.75
EPS Next 2Y8.03%
EPS Next 3Y6.2%

More info and screens

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.43%, CHE is not a good candidate for dividend investing.
The stock price of CHE dropped by -27.61% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
CHE's Dividend Yield is a higher than the industry average which is at 2.61.
With a Dividend Yield of 0.43, CHE pays less dividend than the S&P500 average, which is at 2.32.
Industry RankSector Rank
Dividend Yield 0.43%

5.2 History

The dividend of CHE is nicely growing with an annual growth rate of 8.02%!
CHE has paid a dividend for at least 10 years, which is a reliable track record.
CHE has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)8.02%
Div Incr Years16
Div Non Decr Years21
CHE Yearly Dividends per shareCHE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

9.19% of the earnings are spent on dividend by CHE. This is a low number and sustainable payout ratio.
CHE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP9.19%
EPS Next 2Y8.03%
EPS Next 3Y6.2%
CHE Yearly Income VS Free CF VS DividendCHE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CHE Dividend Payout.CHE Dividend Payout, showing the Payout Ratio.CHE Dividend Payout.PayoutRetained Earnings

More info and screens

CHEMED CORP

NYSE:CHE (7/31/2025, 2:31:25 PM)

415.18

-1.39 (-0.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners96.53%
Inst Owner Change-1.17%
Ins Owners1.59%
Ins Owner Change1.65%
Market Cap6.07B
Analysts85.71
Price Target659.6 (58.87%)
Short Float %2.71%
Short Ratio2.54
Dividend
Industry RankSector Rank
Dividend Yield 0.43%
Yearly Dividend1.83
Dividend Growth(5Y)8.02%
DP9.19%
Div Incr Years16
Div Non Decr Years21
Ex-Date05-29 2025-05-29 (0.5)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.09%
Min EPS beat(2)-0.31%
Max EPS beat(2)0.5%
EPS beat(4)1
Avg EPS beat(4)-1.51%
Min EPS beat(4)-3.17%
Max EPS beat(4)0.5%
EPS beat(8)3
Avg EPS beat(8)-1.04%
EPS beat(12)6
Avg EPS beat(12)-0.62%
EPS beat(16)10
Avg EPS beat(16)1.17%
Revenue beat(2)0
Avg Revenue beat(2)-0.29%
Min Revenue beat(2)-0.38%
Max Revenue beat(2)-0.19%
Revenue beat(4)0
Avg Revenue beat(4)-1.02%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)-0.19%
Revenue beat(8)1
Avg Revenue beat(8)-1.12%
Revenue beat(12)2
Avg Revenue beat(12)-1.02%
Revenue beat(16)4
Avg Revenue beat(16)-0.8%
PT rev (1m)-4.53%
PT rev (3m)-5.94%
EPS NQ rev (1m)-16%
EPS NQ rev (3m)-14.75%
EPS NY rev (1m)-7.71%
EPS NY rev (3m)-7.38%
Revenue NQ rev (1m)-2.55%
Revenue NQ rev (3m)-1.95%
Revenue NY rev (1m)-3.04%
Revenue NY rev (3m)-2.6%
Valuation
Industry RankSector Rank
PE 18.56
Fwd PE 15.37
P/S 2.44
P/FCF 19.28
P/OCF 16.61
P/B 5.14
P/tB 14.3
EV/EBITDA 12.42
EPS(TTM)22.37
EY5.39%
EPS(NY)27.01
Fwd EY6.5%
FCF(TTM)21.53
FCFY5.19%
OCF(TTM)25
OCFY6.02%
SpS170.13
BVpS80.78
TBVpS29.04
PEG (NY)10.15
PEG (5Y)1.75
Profitability
Industry RankSector Rank
ROA 17.88%
ROE 26.13%
ROCE 28.8%
ROIC 22.08%
ROICexc 25.12%
ROICexgc 62.73%
OM 16.62%
PM (TTM) 12.4%
GM 34.82%
FCFM 12.66%
ROA(3y)17.25%
ROA(5y)18.8%
ROE(3y)27.61%
ROE(5y)32.28%
ROIC(3y)21.96%
ROIC(5y)22.92%
ROICexc(3y)25.21%
ROICexc(5y)25.79%
ROICexgc(3y)67.33%
ROICexgc(5y)75.46%
ROCE(3y)28.73%
ROCE(5y)30.03%
ROICexcg growth 3Y-5.61%
ROICexcg growth 5Y0.34%
ROICexc growth 3Y-1.58%
ROICexc growth 5Y4.43%
OM growth 3Y-0.29%
OM growth 5Y3.39%
PM growth 3Y-0.36%
PM growth 5Y1.83%
GM growth 3Y-0.79%
GM growth 5Y1.99%
F-Score7
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 80.07%
Cap/Sales 2.03%
Interest Coverage 250
Cash Conversion 76.69%
Profit Quality 102.04%
Current Ratio 1.73
Quick Ratio 1.7
Altman-Z 11.35
F-Score7
WACC9.15%
ROIC/WACC2.41
Cap/Depr(3y)89.59%
Cap/Depr(5y)94.39%
Cap/Sales(3y)2.41%
Cap/Sales(5y)2.56%
Profit Quality(3y)107.8%
Profit Quality(5y)110.23%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.97%
EPS 3Y6.14%
EPS 5Y10.64%
EPS Q2Q%-21.94%
EPS Next Y1.83%
EPS Next 2Y8.03%
EPS Next 3Y6.2%
EPS Next 5YN/A
Revenue 1Y (TTM)7.37%
Revenue growth 3Y4.36%
Revenue growth 5Y4.63%
Sales Q2Q%3.85%
Revenue Next Year5.26%
Revenue Next 2Y5.73%
Revenue Next 3Y5.44%
Revenue Next 5YN/A
EBIT growth 1Y10.75%
EBIT growth 3Y4.05%
EBIT growth 5Y8.18%
EBIT Next Year29.61%
EBIT Next 3Y12.91%
EBIT Next 5YN/A
FCF growth 1Y51.76%
FCF growth 3Y13.77%
FCF growth 5Y8.19%
OCF growth 1Y35.8%
OCF growth 3Y10.6%
OCF growth 5Y6.75%